A candidate activation pathway for coagulation factor VII.

Area of Science:

• Biochemistry
• Hematology
• Molecular Biology

Background:

• The initiating protease of the extrinsic blood coagulation pathway (factor VIIa) is not fully understood.
• Congenital factor IX deficiency is linked to decreased plasma factor VIIa, suggesting factor IX activation is involved in factor VIIa generation.
• Factor VIIa activates factor IX through two cleavage sites (R191 and R226), producing factor IXa. A variant, factor IXaα, is cleaved only at R226.

Purpose of the Study:

• To investigate the hypothesis that factor IXaα activates factor VII.
• To explore a potential reciprocal activation pathway between factor IX and factor VII in blood coagulation.

Main Methods:

• Utilized a mutant factor IX that generates only factor IXaα upon activation.
• Assayed the coagulant activity of factor IXaα compared to factor IXa.
• Measured the efficiency of factor IXaα and factor IXa in activating factor X.
• Determined the amidolytic activity and kinetic parameters of factor IXaα and factor IXa in converting factor VII to factor VIIa, with and without phospholipids, factor VIIIa, or tissue factor.

Main Results:

• Factor IXaα exhibited 1.6% of the coagulant activity of factor IXa and was less efficient in activating factor X.
• Factor IXaα and factor IXa displayed indistinguishable amidolytic activity.
• Both factor IXaα and factor IXa catalyzed the conversion of factor VII to factor VIIa with similar kinetics, enhanced by phospholipids but not by factor VIIIa or tissue factor.

Conclusions:

• Factor IXa and factor IXaα appear to participate in a reciprocal activation pathway of factor VII and factor IX.
• This proposed pathway does not require a protein cofactor.
• The precise initiating protease for the extrinsic coagulation pathway remains uncertain, potentially involving either factor VIIa or activated factor IX.